Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-25-054428
Filing Date
2025-06-16
Accepted
2025-06-13 19:45:20
Documents
5
Effectiveness Date
2025-06-16

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0244817-s8_inmune.htm S-8 169415
2 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea024481701ex5-1_inmune.htm EX-5.1 6129
3 CONSENT OF MARCUM LLP ea024481701ex23-1_inmune.htm EX-23.1 1592
4 FILING FEE TABLE ea024481701ex-fee_inmune.htm EX-FILING FEES 24620
5 GRAPHIC ex5-1_001.jpg GRAPHIC 16489
  Complete submission text file 0001213900-25-054428.txt   225645
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-288058 | Film No.: 251048150
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)